thoughts on fair market cap assuming trials replicate or improve on results already seen?
It’s obviously a bit of an art at this early stage, but since buying soon after IPO I’ve had $120m as a target that I think is not unreasonable considering peers and realistic chance of revenues flowing by 2026
keen to hear views of others
above not financial advice!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
-0.010(2.41%) |
Mkt cap ! $45.34M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 43.5¢ | 39.0¢ | $161.6K | 392.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 150534 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| LTP (ASX) Chart |